A Summary of ALECSAT
Cell-based immunotherapy such as ALECSAT is well tolerated and have very few side effects as demonstrated in all clinical programs.
ALECSAT has specificity for and recognizes different cancer-specific antigens.
ALECSAT will also be efficacious in patients with inhibited immune defense mechanisms.
ALECSAT has three potential modes of actions:
- Direct cancer-cell destruction by way of the cytotoxic T lymphocytes (CTL’s) and natural killer (NK) cells administered via injection to the patient.
- Persistent cancer-cell destruction as the ALECSAT cells will continue to divide to higher numbers of new CTL’s.
- Reactivation of the patient’s own immune system may also lead to persistent destruction of new cancer cells.
